Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-07 @ 8:41 PM
Study NCT ID:
NCT01701856
Status:
TERMINATED
Last Update Posted:
2014-01-22
First Post:
2012-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
Sponsor:
Claudio Gobbi
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
EOC.NSI.11.01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |